Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Arcus Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $2.12M in total
- Insiders trading
- 2
- Net value
- −$2.12M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Arcus Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Azoy Alexander | Chief Accounting Officer | 39,581 | Aug 24, 2026 | 6 |
| Jaen Juan C. | President | 822,240Indirect | Jul 13, 2026 | 9 |
| Perlman Andrew J | Director | 48,325 | Jun 12, 2026 | 1 |
| Falberg Kathryn E | Director | 44,300 | Jun 12, 2026 | 1 |
| Kaneko Yasunori | Director | 25,700 | Jun 12, 2026 | 1 |
| Machado Patrick | Director | 44,300 | Jun 12, 2026 | 1 |
| Lacey David L. | Director | 76,652 | Jun 12, 2026 | 1 |
| Lambert Nicole | Director | 43,000 | Jun 12, 2026 | 1 |
| Ribas Antoni | Director | 44,300 | Jun 12, 2026 | 2 |
| Tang Carolyn C. | General Counsel | 184,607 | Jun 12, 2026 | 3 |
| Goeltz II Robert C. | Chief Financial Officer | 84,161 | May 12, 2026 | 6 |
| Rosen Terry J | Chief Executive Officer | 2,236,409 | Jan 26, 2026 | 4 |
| Jarrett Jennifer | Chief Operating Officer | 224,024 | Jan 26, 2026 | 4 |
| Markus Richard | Chief Medical Officer | 89,647 | Jan 26, 2026 | 2 |
| Gilead Sciences, Inc. | 10% Owner | 31,424,760 | Feb 20, 2025 | 0 |
| Nuyten Dimitry SA | Chief Medical Officer | 87,518 | Dec 17, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2022 (view filing) | Dec 16 | Same day | Tang Carolyn C.General Counsel | SSale | −2.52K | $30.75 | −$77.6K | −8.1%28.6K after | 2 lots |
| Dec 16, 2022 (view filing) | Dec 16 | Same day | Jarrett JenniferChief Operating Officer | SSale | −16.5K | $30.75 | −$506.8K | −10.0%147.6K after | 2 lots |
| Dec 16, 2022 (view filing) | Dec 16 | Same day | Jaen Juan C.President | SSale | −4.44K | $30.75 | −$136.4K | −2.0%218.3K after | 2 lots |
| Dec 16, 2022 (view filing) | Dec 16 | Same day | Rosen Terry JChief Executive Officer | SSale | −13.0K | $30.75 | −$401.1K | −5.1%242.2K after | 2 lots |
| Sep 20, 2022 (view filing) | Sep 16 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −12.7K | $26.28 | −$333.2K | −8.8%130.9K after | |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Tang Carolyn C.General Counsel | SSale | −2.92K | $21.45 | −$62.7K | −10.9%23.9K after | 3 lots |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Rosen Terry JChief Executive Officer | SSale | −8.85K | $21.45 | −$189.9K | −3.7%227.7K after | 3 lots |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Jarrett JenniferChief Operating Officer | SSale | −12.7K | $21.45 | −$272.3K | −9.7%118.6K after | 3 lots |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Jaen Juan C.President | SSale | −4.87K | $21.45 | −$104.5K | −2.3%210.0K after | 3 lots |
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −9.62K | $31.62 | −$304.1K | −8.3%106.0K after | |
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −34.8K | $41.48 | −$1.44M | −27.8%90.6K after | 3 lots |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Tang Carolyn C.General Counsel | SSale | −1.11K | $40.12 | −$44.5K | −5.9%17.6K after | 6 lots |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Goeltz II Robert C.Chief Financial Officer | SSale | −1.11K | $40.12 | −$44.4K | −13.6%7.02K after | 6 lots |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Jaen Juan C.President | SSale | −1.97K | $40.12 | −$79.2K | −1.0%201.2K after | 6 lots |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Jarrett JenniferChief Operating Officer | SSale | −12.7K | $40.12 | −$508.7K | −9.2%125.4K after | 6 lots |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Rosen Terry JChief Executive Officer | SSale | −5.24K | $40.12 | −$210.3K | −2.4%211.6K after | 6 lots |
| Sep 22, 2021 (view filing) | Sep 20-21 | 2 days | Jarrett JenniferChief Operating Officer | SSale | −47.5K | $35.35 | −$1.68M | −29.6%112.8K after | 5 lots |